Garascia Jessica A. 4

4 · AAR CORP · Filed Jul 25, 2025

Form 4

Period: 2025-07-23

Senior VP, GC, CAO & Secretary

Transactions

Exercise/Conversion
Stock Option
2025-07-23−1,183→ 1,579 total
Exercise: $41.88From: 2023-07-31Exp: 2032-07-18→ Common Stock (1,183 underlying)
Exercise/Conversion
Common Stock
2025-07-23$41.88/sh+1,183$49,544→ 40,300 total
Exercise/Conversion
Stock Option
2025-07-23−1,559→ 0 total
Exercise: $37.74From: 2022-07-31Exp: 2031-07-12→ Common Stock (1,559 underlying)
Award
Common Stock
2025-07-23+2,115→ 32,772 total
Sale
Common Stock
2025-07-23$77.08/sh−1,183$91,183→ 39,117 total
Sale
Common Stock
2025-07-23$77.08/sh−889$68,522→ 39,117 total
Exercise/Conversion
Stock Option
2025-07-23−889→ 2,965 total
Exercise: $58.27From: 2024-07-31Exp: 2033-07-24→ Common Stock (889 underlying)
Award
Stock Option
2025-07-23+5,850→ 5,850 total
Exercise: $79.45From: 2026-07-31Exp: 2035-07-23→ Common Stock (5,850 underlying)
Award
Common Stock
2025-07-23+6,345→ 39,117 total
Exercise/Conversion
Common Stock
2025-07-23$37.74/sh+1,559$58,837→ 40,676 total
Sale
Common Stock
2025-07-23$77.08/sh−1,559$120,165→ 39,117 total
Exercise/Conversion
Common Stock
2025-07-23$58.27/sh+889$51,802→ 40,006 total

Footnotes (7)

[F1]Award of stock pursuant to Restricted Stock Agreement in transaction exempt under Rule 16b-3.
[F2]Award of stock pursuant to a Performance Restricted Stock Agreement in a transaction exempt under Rule 16b-3.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.43 to $79.16 inclusive. The reporting person undertakes to provide AAR CORP. any security holder of AAR CORP. or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2026 and shall vest as follows: 33 and 1/3% on each of July 31, 2026, July 31, 2027 and July 31, 2028.
[F5]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2022 and vested as follows: 33 and 1/3% on each of July 31, 2022, July 31, 2023, and July 31, 2024.
[F6]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2023 and shall vest as follows: 33 and 1/3% on each of July 31, 2023, July 31, 2024, and July 31, 2025.
[F7]The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2024 and shall vest as follows: 33 and 1/3% on each of July 31, 2024, July 31, 2025, and July 31, 2026.

Documents

2 files